Wobble Genomics Appoints Dr. Dietrich A. Stephan as Chairman of the Board of Directors
May 6, 2025
Wobble Genomics, a biotechnology company working to improve outcomes in cancer through better diagnosis and therapy selection, via a novel ultra-sensitive cell-free RNA liquid biopsy